Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ARDX
ARDX logo

ARDX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ARDX News

Ardelyx CEO Michael Raab Executes Stock Sale

Apr 03 2026NASDAQ.COM

Ardelyx CEO Sells Shares for Approximately $243,000

Apr 03 2026Fool

Ardelyx Appoints New Chief Medical Officer

Apr 01 2026NASDAQ.COM

Ardelyx CEO's Stock Sale Raises Investor Interest

Mar 02 2026Fool

Ardelyx CEO's Stock Sale and Earnings Highlights

Mar 02 2026NASDAQ.COM

Ardelyx Shares Rise on Insider Purchase and LPGA Partnership

Feb 24 2026seekingalpha

Ardelyx Director's Share Purchase Boosts Investor Confidence

Feb 24 2026stocktwits

Trump Announces Global Tariff Increase to 15%

Feb 23 2026stocktwits

ARDX Events

04/20 08:30
Ardelyx Appoints Felecia Ettenberg as Chief Legal Officer
Ardelyx announced the appointment of Felecia Ettenberg, a seasoned leader with more than 25 years of legal experience in the biopharmaceutical industry, as Chief Legal Officer, CLO. She will oversee Ardelyx's legal, compliance, regulatory, and government affairs operations. Ettenberg succeeds Elizabeth Grammer, who has chosen to retire after an extraordinary 16-year career at the company.
04/01 08:20
Ardelyx Appoints Rajani Dinavahi as Chief Medical Officer
Ardelyx (ARDX) announced the appointment of Rajani Dinavahi as chief medical officer. Dinavahi brings more than two decades of experience in healthcare and biotechnology, spanning multiple therapeutic areas and modalities. Dinavahi most recently served as senior VP, chief medical officer at Atara Biotherapeutics (ATRA).
03/05 07:40
Zevra Therapeutics Appoints Justin Renz as CFO
Zevra Therapeutics (ZVRA) announced the appointment of Justin Renz as Chief Financial Officer, effective March 9, 2026. Renz most recently served as Chief Financial & Operations Officer at Ardelyx (ARDX)
02/24 08:20
Ardelyx Becomes Official Partner of LPGA
The Ladies Professional Golf Association, LPGA, and Ardelyx announced a multi-year partnership naming Ardelyx as an official corporate pharmaceutical Marketing Partner of the LPGA Tour. The exclusive partnership unites two organizations dedicated to empowering women to take control of their health. "This partnership represents a natural alignment between Ardelyx's mission and the LPGA's platform to support the digestive health of women, who account for more than 90 percent of those living with conditions like irritable bowel syndrome with constipation, yet many suffer in silence due to stigma and lack of awareness," said Eric Foster, chief commercial officer of Ardelyx. "By partnering with the LPGA, we will engage with our shared audience, not just as golf fans, but as individuals who deserve open conversations about their health. At the heart of this first-of-its-kind partnership is the ambition to educate and mobilize patients to be proactive in their health, talk to their doctor and imagine a healthier tomorrow. The LPGA's commitment to empowering women on and off the course makes them the ideal partner to help us amplify patient voices and break down barriers to care."

ARDX Monitor News

Ardelyx Reports Strong Revenue Growth Amid Analyst Concerns

Feb 20 2026

Zydus Lifesciences in Talks to Acquire Ardelyx, Stock Rises

Jan 20 2026

Ardelyx Inc reports significant revenue growth for IBSRELA

Jan 08 2026

ARDX Earnings Analysis

No Data

No Data

People Also Watch